Give your patients the opportunity to stay on branded TRINTELLIX for little to no cost over the generic medication*
* The TRINTELLIX Patient Choice Card Program is available in all provinces except Quebec. Depending on the benefit type and patient’s existing coverage, the card will pay all or some of the drug acquisition cost and applicable markup.
CONSIDER TRINTELLIX FOR YOUR PATIENTS WITH MDD (MAJOR DEPRESSIVE DISORDER)
TRINTELLIX (vortioxetine) is indicated for the treatment of MDD in adults.1
Financial assistance for your patients on branded TRINTELLIX
The new Patient Choice Card* is easy for your patients to use.
Step 1: Patients get their TRINTELLIX Patient Choice Card* at trintellix-support.ca.
Step 2: They present their card at the pharmacy along with their TRINTELLIX prescription.
Make sure to write “as prescribed” or “dispense as written” so that your patients will receive exactly what you prescribed.
Need samples or more information about TRINTELLIX?
† Clinical significance is unknown.
‡ Estimated treatment time was calculated based on 3 months to 2 years.
* Not available in Quebec.
MOA=mechanism of action
§ See guidelines for complete recommendations.
References: 1. TRINTELLIX Product Monograph. Lundbeck Canada Inc., May 27, 2024. 2. Data on file. Lundbeck Canada Inc. February 2025. 3. Lam RW, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Can J Psychiatry 2024:1-47.
